Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Bioanalysis|October 4, 2021
Validation of enantioseparation and quantitation of an active metabolite of abrocitinib in human plasmaSakambari Tripathy, Daria Wentzel, Xia Katty Wan, et al.Contraception|July 2, 2026
A phase 1, randomized, open-label, single-dose relative bioavailability study of upper arm injection of depot medroxyprogesterone acetate comparing pharmacokinetics and hormone indicators of ovulation with anterior thigh and abdomen injectionNancy Sherman, Sakambari Tripathy, Isabelle Huyghe, et al.Bioanalysis|September 5, 2024
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso deviceSakambari Tripathy, Katty X Wan, Mohamed H Shahin, et al.Journal of Clinical Pharmacology|March 22, 2021
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Melissa O'Gorman, et al.Chemical Research in Toxicology|January 24, 2009
Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fractionJonathon N Bauman, Joan M Kelly, Sakambari Tripathy, et al.Journal of Clinical Pharmacology|October 12, 2021
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Jennifer A Winton, et al.Antimicrobial Agents and Chemotherapy|July 16, 2024
A phase 1 open label study to assess the human mass balance and metabolite profile of 14C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participantsMichael R Hodges, Eric Ople, Philip Evans, et al.Clinical and Translational Science|February 16, 2024
Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participantsAarti Sawant-Basak, Arthur J Bergman, Jessica Mancuso, et al.European Journal of Drug Metabolism and Pharmacokinetics|March 30, 2024
Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy IndividualsXiaoxing Wang, Martin E Dowty, Sakambari Tripathy, et al.Clinical Pharmacology and Therapeutics|March 28, 2022
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous BiomarkersManoli Vourvahis, Wonkyung Byon, Cheng Chang, et al.Pageof 2